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Introduction
Pax proteins are key regulators of developmental processes
including specification, differentiation, growth, survival,
migration and morphogenesis (Chi and Epstein, 2002; Dahl et
al., 1997; Mansouri et al., 1996; Stuart et al., 1994). Pax genes
are present in organisms ranging from worms to mammals
(Czerny et al., 1997; Dahl et al., 1997; Walther et al., 1991).
Pax proteins are named for and defined by the presence of a
highly conserved, N-terminal, 128-amino acid DNA-binding
domain, the Paired domain (PD), which was first identified in
the Drosophila pair-rule segmentation gene paired (Treisman
et al., 1991). The PD consists of two subdomains that each bind
DNA in adjacent major grooves of the helix (Xu et al., 1995).
Several Pax proteins can also interact with DNA via a complete
or partial homeodomain (Dahl et al., 1997; Stuart et al., 1994;
Underhill and Gros, 1997). Transcriptional activity of Pax
proteins is controlled by a C-terminal regulatory region
containing both activating and inhibitory domains (Dorfler and
Busslinger, 1996).
Extensive alternative splicing has been reported for many
vertebrate Pax genes, including mammalian Pax2, Pax3, Pax5,
Pax6, Pax7 and Pax8, and zebrafish pax2a, pax3, pax7, and
pax9 (Barber et al., 1999; Barr et al., 1999; Epstein et al., 1994;
Kozmik et al., 1997; Kozmik et al., 1993; Nornes et al., 1996;
Puschel et al., 1992; Seo et al., 1998; Tavassoli et al., 1997;
Vogan et al., 1996; Zwollo et al., 1997). Similarly, Pax2/5/8
transcripts of the invertebrate chordate amphioxus
(Branchiostoma floridae) are alternatively spliced (Krelova et
al., 2002). In most cases, alternative splicing has been shown
to produce protein isoforms with drastically different DNA
binding specificities and transactivation potentials (Barber et
al., 1999; Barr et al., 1999; Epstein et al., 1994; Kozmik et al.,
1997; Kozmik et al., 1993; Nornes et al., 1996; Puschel et al.,
1992; Seo et al., 1998; Tavassoli et al., 1997; Vogan et al.,
1996; Zwollo et al., 1997). Thus, alternative splicing is a highly
conserved means of increasing the functional repertoire of Pax
genes.
The nine vertebrate Pax genes are grouped into four
categories, with Pax2/5/8 constituting one of these classes
Vertebrate Pax2 and Pax8 proteins are closely related
transcription factors hypothesized to regulate early aspects
of inner ear development. In zebrafish and mouse, Pax8
expression is the earliest known marker of otic induction,
and Pax2 homologs are expressed at slightly later stages of
placodal development. Analysis of compound mutants has
not been reported. To facilitate analysis of zebrafish pax8,
we completed sequencing of the entire gene, including the
5′ and 3′ UTRs. pax8 transcripts undergo complex
alternative splicing to generate at least ten distinct
isoforms. Two different subclasses of pax8 splice isoforms
encode different translation initiation sites. Antisense
morpholinos (MOs) were designed to block translation
from both start sites, and four additional MOs were
designed to target different exon-intron boundaries to
block splicing. Injection of MOs, individually and in
various combinations, generated similar phenotypes. Otic
induction was impaired, and otic vesicles were small.
Regional ear markers were expressed correctly, but hair
cell production was significantly reduced. This phenotype
was strongly enhanced by simultaneously disrupting either
of the co-inducers fgf3 or fgf8, or another early regulator,
dlx3b, which is thought to act in a parallel pathway. In
contrast, the phenotype caused by disrupting foxi1, which
is required for pax8 expression, was not enhanced by
simultaneously disrupting pax8. Disrupting pax8, pax2a
and pax2b did not further impair otic induction relative
to loss of pax8 alone. However, the amount of otic
tissue gradually decreased in pax8-pax2a-pax2b-deficient
embryos such that no otic tissue was detectable by 24 hours
post-fertilization. Loss of otic tissue did not correlate
with increased cell death, suggesting that otic cells
dedifferentiate or redifferentiate as other cell type(s). These
data show that pax8 is initially required for normal otic
induction, and subsequently pax8, pax2a and pax2b act
redundantly to maintain otic fate.
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(Pfeffer et al., 1998). This is an ancient group, with orthologs
present in echinoderms, nematodes, and flies (Czerny et al.,
1997). The sequences of the functional regions are nearly
invariant among the vertebrate Pax2/5/8 genes (Pfeffer et al.,
1998). Pax2/5/8 genes are expressed in a spatially and
temporally overlapping manner at the midbrain-hindbrain
junction and in the CNS; this expression pattern has been
conserved from zebrafish to mouse (Pfeffer et al., 1998). Pax2
and Pax8 homologs are also expressed in the otic placode and
pronephros in these species (Pfeffer et al., 1998; Plachov et al.,
1990). Recent evidence has shown that Pax2 and Pax8 perform
redundant functions during mammalian kidney development
and are required for the earliest steps of this process (Bouchard
et al., 2002; Mansouri et al., 1998). However, otic development
in Pax2/Pax8-deficient mouse embryos has not yet been
described. In both zebrafish and mouse, Pax8 is strongly
expressed in the primordium of the otic placode during late
gastrulation, making it the earliest known marker of otic
induction (Pfeffer et al., 1998). Pax8 expression is maintained
throughout placode development and is lost soon after
formation of the otic vesicle (Pfeffer et al., 1998). Pax2
homologs are expressed in the otic anlagen during early
somitogenesis stages and are maintained in portions of the otic
vesicle (Pfeffer et al., 1998). The Pax8 knockout mouse does
not show an otic phenotype (Bouchard et al., 2002; Mansouri
et al., 1998), and the Pax2 knockout mouse shows variable
defects in derivatives of the medial otic vesicle where Pax2 is
expressed after the vesicle forms (Bouchard et al., 2000;
Burton et al., 2004; Favor et al., 1996; Torres et al., 1996). The
absence of an earlier or more severe phenotype may reflect
redundancy between these genes. There are two Pax2
homologs in zebrafish, pax2a and pax2b, and functional
disruption of both genes reduces hair cell production but does
not impair formation of the placode or vesicle (Whitfield et al.,
2002). The extent to which pax8 compensates for loss of pax2a
and pax2b is not known.
Several upstream regulators of otic induction have been
identified. The forkhead class transcription factor gene foxi1 is
expressed in the ventral ectoderm beginning at 50% epiboly.
By mid-gastrulation foxi1 expression is upregulated in the
future otic placode prior to induction of pax8. Loss of foxi1
prevents expression of pax8 in the otic domain and severely
compromises otic induction. Furthermore, misexpression of
foxi1 is sufficient to induce ectopic pax8 (Nissen et al., 2003;
Solomon et al., 2003). At least two other genes, fgf3 and fgf8,
are also necessary for pax8 expression. These genes encode Fgf
ligands that are expressed in the developing hindbrain between
the prospective otic placodes. Loss of both fgf genes blocks otic
induction, whereas misexpression of either gene is sufficient to
induce ectopic otic tissue (Leger and Brand, 2002; Maroon et
al., 2002; Phillips et al., 2001; Phillips et al., 2004). Thus, Fgf
signaling and foxi1 function converge to induce pax8,
suggesting that pax8 could be an important mediator of otic
induction. In addition, zebrafish dlx3b and dlx4b, transcription
factors with homeo-domains similar to Drosophila distal-less
(Ekker et al., 1992a; Ellies et al., 1997), are required for otic
placode formation. Combined loss of function of dlx3b/4b
leads to a reduction or absence of otic placodes and pax2a
expression in otic cells, but pax8 expression initiates normally
(Liu et al., 2003; Solomon and Fritz, 2002).
In this paper, we describe a role for pax8 during otic
development. We have cloned full-length transcripts of
zebrafish pax8 and show that there are three main splice
variants that encode proteins with different N-terminal
sequences. Depletion of Pax8 function leads to compromised
otic vesicle and inner ear morphology, and our data suggest
that different isoforms have both overlapping and unique
functions. We show a strong genetic interaction between pax8
and pax2a, and to a lesser extent pax2b, implicating these
genes in the maintenance of otic cell fate. Depletion of pax8
enhances otic placode and vesicle defects in embryos with
reduced Fgf signaling or in embryos that have been depleted
for dlx3b function. In contrast, depletion of pax8 does not
enhance defects in embryos depleted for foxi1. These and other
data support the hypothesis that pax8 helps mediate otic
induction downstream of foxi1 and fgf3 and 8 but in parallel
with dlx3b. At later stages, pax8 acts redundantly with Pax2
genes to maintain otic fate.
Materials and methods
Fish strains
Embryos were developed at 28.5°C and staged according to standard
criteria (Kimmel et al., 1995). Wild-type fish were derived from the
AB line. noitu29a and aceti282a were derived from the Tu line (Brand
et al., 1996) and used to assess functions of pax2a and fgf8,
respectively. noitu29a is thought to be a null allele (Lun and Brand,
1998) whereas aceti282a is a strong hypomorph (Draper et al., 2001).
Because pax2a and fgf8 are closely linked, producing ace-noi double
homozygotes required that we first produce a recombinant line in
which both mutant loci reside on the same chromosome. The rate of
recombination between fgf8 and pax2a is roughly 1.5%, so nearly
25% of intercross progeny produced in this line are double
homozygotes.
pax8 5′ and 3′ RACE cloning and sequencing
RNA was isolated from 3-5 somite and 24-hour embryos using
TRIPURE reagent (Roche). For the 5′ RACE reaction, 3-5 somite
stage RNA was processed using the First Choice RLM-RACE kit from
Ambion. cDNA was synthesized using a pax8-specific primer
(CAGCGCCGCGGAGGGAAAGT) and C. therm polymerase
(Roche) at 68°C for reverse transcription. Subsequently, PCR
was performed using a second, nested pax8-specific primer
(GCGGCGGTCGATTGGCAAAACTGTA) and the 5′ RACE adaptor
outer primer (Ambion). A fraction of this reaction was used as
template in a second PCR amplification with a third, nested pax8-
specific primer (AACGGGCGCAGATGACGGAGACGAA) and the
5′ RACE adaptor inner primer. All PCRs were performed using the
Clontech Advantage-GC2 protocol with a final concentration of 1 M
GC-melt. The resulting amplification products were cloned into pCRII
Topo vector (Invitrogen) and sequenced. The 24-hour RNA was
reverse transcribed using the CDS primer from the SMART II kit
(Clontech) and C. Therm polymerase. 3′ RACE was performed using
a pax8-specific primer (CATCAATGGGCTGCTGGGAATCA) and
the CDS primer (Clontech) in an initial PCR. A fraction of this
reaction was used for a second PCR amplification with a nested pax8-
specific primer (TCCGAGGGCTGAGGTATTTGTC) and the PCR
primer supplied in the Clontech SMART II kit. A third round of PCR
was performed using a fraction of the second PCR reaction
as template and the pax8-specific primer (GCCAGTTC-
AGCAGCCCGTCCCTCAT) and the PCR primer (Clontech). The
resulting products were cloned into the pCRII Topo vector and
sequenced.
For the splice variant analysis, pax8-specific primers located in the
5′ UTR [exon 1a (Fig. 1A); GACAGACAACGGCGAACACCAA-
CAC] and the 3′UTR [exon 13 (Fig. 1A); ACCCGGCCTCAG-
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Fig. 1. Sequence and splice variants of pax8. (A) The complete sequence of the pax8
variant 3 transcript. Exons predicted by comparison to genomic sequence are indicated
above the sequence. The transcription start site, preceded by a TATAA box, begins with
exon 1a. Exon 1 is contiguous with genomic DNA sequence, but has been subdivided
into exons 1a, 1b, and 1c to indicate that the splice variants shown in Fig. 1B contain
different parts of exon 1. The arrow indicates the putative start codon used in variant 1
transcripts. The star indicates that some transcripts use an alternate splice donor site
that extends exon 9 by 33 bp (sequence not shown). The canonical Paired domain and
predicted transactivation and inhibitory domains are indicated below the sequence.
Polyadenylation (polyA) sites are underlined in purple; the majority of transcripts
(52/54) use the first polyA site. (B) A schematic representation (not to scale) of the
splice variants observed in pax8 transcripts. The variant name (e.g. 1.1, 1.2), total
number of representative transcripts out of 54 total sequenced, and percentage
abundance are indicated after each schematic transcript. The unlabeled box between
exon 9 and exon 10 in variants 1.4 and 1.5 indicates an additional 11 amino acid insert
(see also Fig. 1A) resulting from the use of an alternate splice donor site. The predicted
coding sequence for variants 2 and 3 begins with the start codon in exon 1c; all variant
1 transcripts use the start codon in exon 2 indicated by the arrow in Fig. 1A.
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CTCAACATCAATAG] were used to amplify pax8 transcripts from
24-hour cDNA (described above), using the Advantage-GC2 PCR
protocol with a 1 M concentration of GC-melt. The resulting products
were cloned into the pCRII Topo vector and sequenced.
Morpholino injections
Morpholino oligomers obtained from Gene Tools Inc. were diluted
and injected as previously described (Nasevicius and Ekker, 2000;
Phillips et al., 2001). A total of 1-5 ng MO was injected per embryo.
At least 25 specimens were examined for each experiment.
To knockdown pax8, translation-blocking morpholinos and splice-
blocking morpholinos were generated as follows: translation blocker
for splice variant 1 (variant 1 MO): 5′ GTTCACAAACATGCCTCC-
TAGTTGA 3′; translation blocker for splice variants 2 and 3 (variant
2/3 MO): 5′ GACCTCGCCCAGTGCTGTTGGACAT 3′; splice
blocker exon6/7 (splice donor site): 5′ CTGCACTCACTGT-
CATCGTGTCCTC 3′; splice blocker exon6/7 (splice acceptor site): 5′
CAGCTCTCCTGGTCACCTGCACAAC 3′; splice blocker exon3
(paired domain): 5′ GTAGCGGTGACACACCCCCTCGGCC 3′;
splice blocker exon7/8 (homeo domain): 5′ TGCGGTGTTCTGCAC-
CTGCTCTGCT 3′. Unless stated otherwise, pax8 morphants were
injected with 2.5 ng each of variant 1 MO and variant 2/3 MO to
maximally disrupt pax8 function.
To knockdown fgf3, two translation-blocking sequences were co-
injected: fgf3-MO #1, 5′ CATTGTGGCATCGCGGGATGTCGGC 3′;
fgf3-MO #2, 5′ GGTCCCATCAAAGAAGTATCATTTG 3′. Other
morpholino sequences used were as follows: dlx3b-MO translation
blocker, 5′ ATATGTCGGTCCACTCATCCTTTAAT 3′; foxi1-MO
translation blocker, 5′ TAATCCGCTCTCCCTCCAGAAA 3′; pax2b-
MO translation blocker: 5′ GGTCTGCCTTACAGTGAATATCCAT
3′.
Immunofluorescent staining
Embryos were raised in 0.3% PTU solution to inhibit the formation
of melanocytes. Embryos were fixed and stained as previously
described (Riley et al., 1999) using polyclonal anti-mouse Pax2
antibody (Berkeley Antibody company, 1:100 dilution) and
monoclonal anti-acetylated tubulin antibody (Sigma T-6793, 1:100).
Alexa 546 goat anti-rabbit IgG (Molecular Probes A-11010, 1:50) and
Alexa 488 goat anti-mouse IgG (Molecular Probes A-11001, 1:50)
were used as secondary antibodies.
In situ hybridization
In situ hybridization was carried out as described in Phillips et al.
(Phillips et al., 2001), and two-color staining was performed as
described by Jowett (Jowett, 1996) with minor modifications.
Antisense riboprobes were transcribed from plasmids containing the
following: dlx3b (Ekker et al., 1992a); krox20 (Oxtoby and Jowett,
1993); msxC (Ekker et al., 1992b); pax2a (Krauss et al., 1991); pax5
and pax8 (Pfeffer et al., 1998).
Results
Pax8 transcript structure
The previously published sequence for zebrafish pax8 was
incomplete, lacking 3′ UTR sequences and 5′ sequences,
including the putative start codon (Pfeffer et al., 1998). In order
to facilitate design of translation-blocking morpholinos,
complete pax8 cDNAs were generated using RACE by RT-
PCR on adaptor ligated mRNA from 3-5 somite stage and 24-
hour embryos. Sequence analysis of the 5′ RACE clones
indicated that pax8 is alternatively spliced, resulting in two
different predicted start codons (Fig. 1A). Because members of
the Pax gene family are subject to alternative splicing (Barber
et al., 1999; Barr et al., 1999; Epstein et al., 1994; Kozmik et
al., 1997; Kozmik et al., 1993; Nornes et al., 1996; Puschel et
al., 1992; Seo et al., 1998; Tavassoli et al., 1997; Vogan et al.,
1996; Zwollo et al., 1997), primers in the predicted 5′ UTR and
3′ UTR were designed and RT-PCR was performed to obtain
a collection of clones containing pax8 transcripts with a
complete coding sequence. A total of 54 clones were randomly
selected and sequenced, and the results of this analysis are
summarized in Fig. 1B. To verify these results, the cDNA
sequences were used to search the genome assembly database
(assembly Zv2; http://www.sanger.ac.uk/Projects/D_rerio/).
Based on this comparison and the previously available data, the
zebrafish pax8 gene consists of at least 13 exons, and we have
renumbered them accordingly (Fig. 1A). The predominant
class of transcripts (32/54, 59.5%; Fig. 1B) is variant 1.1,
which contains exon 1a, then exon 2 and all subsequent exons.
The predicted ORF for variant 1 starts ten amino acids within
the canonical Paired domain and is contiguous with the
previously published sequence. Interestingly, Fugu pax8 also
encodes a methionine at position 10 of the Paired domain
(Pfeffer et al., 1998), and thus may encode a similar set of Pax8
proteins as zebrafish. The second most frequent class of
transcripts (6/54, 11%; Fig. 1B) is variant 2.1, which contains
exon 1a, exon 1c, and then exon 2 and all following exons.
Exon 1c provides an alternate potential start codon, leading to
a predicted protein that starts eight amino acids N-terminal to
the canonical Paired domain (Fig. 1A). Variant 3 transcripts
appear to be rare (2/54, 4% of our clones) and encode the same
predicted protein sequence as variant 2 transcripts.
Variants 1.2 (3.7%) and 2.2 (3.7%) lack exon 11, which
encodes a portion of the transactivation domain. Similarly,
variants 1.3 (5.5%) and 2.3 (3.7%) lack exons 9 and 10, which
also encode part of the transactivation domain. Variants 1.4
(3.7%) and 1.5 (1.8%) use an alternate splice donor site,
leading to an insert between exons 9 and 10; this insert is in
frame and would add 11 amino acids to the transactivation
domain (not shown in Fig. 1A sequence). In addition to the
insert, variant 1.5 also lacks exon 11. Variant 2.6 lacks part of
the transactivation domain due to the absence of exon 9.
The sequence analysis shows that pax8 transcripts are
subject to extensive alternative splicing. To address the
potential functional significance of different Pax8 isoforms,
artificial mRNA for variants 1.1 or 2.1 (full length) and 1.3 or
2.3 (nonfunctional transactivation domain) were injected into
one-cell embryos. Ectopic overexpression of either full length
variant leads to severe gastrulation defects, precluding a
meaningful interpretation of pax8 function in otic placode
formation. Conversely, injection of the isoforms lacking the
transactivation domain did not lead to any detectable
phenotypes in otic placode or vesicle morphology (data not
shown).
Functional analysis of pax8
We designed morpholino oligonucleotides (MO) to knock
down pax8 function. Four MOs were designed to block pre-
mRNA splicing at distinct splice junction sites (Draper et al.,
2001), and two additional MOs were designed to target the
sequence around each of the predicted start codons (Nasevicius
and Ekker, 2000). Together, these two MOs are predicted to
block translation of all isoforms (Fig. 1A). Co-injection of the
translation-blocking MOs resulted in the most consistent and
reproducible phenotypes, and this approach was used in all
Development 132 (2) Research article
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subsequent studies. Co-injection of the two translation
blockers plus two of the four splice-blocking MOs did
not produce any additional phenotypic defects,
although nonspecific necrosis was seen at higher MO
concentrations (not shown), further suggesting that
the translation-blocking MOs effectively block pax8
function.
At 24 hpf, reduction of pax8 translation in embryos
injected with both translation-blocking pax8 MOs
(pax8 morphants) causes a slightly shortened trunk/tail axis
and a reduced midbrain-hindbrain border with mild necrosis
in adjacent brain tissue (Fig. 2A,D). Furthermore, the otic
vesicle is reduced in its linear dimensions by roughly half
(Fig. 2B,E). These phenotypic changes are observed in over
90% of pax8 morphants. Embryos injected with only variant
1 MO (Fig. 2C) or variant 2/3 MO (Fig. 2F) display an otic
vesicle phenotype of intermediate severity, with the variant
2/3 morphant embryos showing a slightly more affected otic
vesicle. Because pax8 is one of the earliest known markers
of preotic development (Pfeffer et al., 1998), we analyzed
the initial stages of otic induction in pax8 morphants.
Knockdown of pax8 does not eliminate pax8 mRNA
expression in otic precursor cells, but reduces the size of the
preotic domain of pax8 expression at all stages examined
(Fig. 2G,J). The level of pax8 expression in these cells is also
reduced, suggesting a certain degree of autoregulation. Two
other preotic markers, pax2a and dlx3b, also display reduced
preotic domains, but levels of expression are relatively
normal (Fig. 2H,K,I,L). Hindbrain (HB) patterning is normal
in pax8 morphants as judged by expression patterns of
krox20, fgf3, fgf8, wnt8 and wnt8b (Fig. 2H,K; see also Fig.
5), suggesting that impairment of preotic development is not
due to loss of HB signals. We infer that a reduced level of
pax8 impairs the response of preplacodal cells to otic-
inducing signals (see Discussion). Alternatively, otic
induction may proceed normally in pax8 morphants, but
placodal cells proliferate less in the absence of Pax8.
However, previously published work on the role of Fgf3 and
Fgf10 during otic development in the mouse suggests that this
latter explanation is not the case (Alvarez et al., 2003; Wright
and Mansour, 2003).
We also examined later aspects of otic patterning in pax8
morphants. General features of anterior-posterior, dorso-
ventral and medio-lateral patterning appear unaffected, as
shown by normal expression of pax5 in the anterior (Fig. 3B,F),
dlx3b in the dorsal (Fig. 3C,G), and pax2a in the ventromedial
portions of the otic vesicle (Fig. 3A,E). However, hair cell
production is reduced by an average of 42±11% (n=59;
compare Fig. 3A and E), and severely affected specimens
produce only a single macula per ear (not shown). Cristae
typically form by 72 hpf and express msxC, although the level
of expression is usually reduced in the lateral crista (Fig.
3D,H). In severely affected specimens with very small otic
vesicles, one or more cristae are fused or missing (not shown).
Later stages of otic development become increasingly aberrant
as embryos begin to degenerate and die (not shown). Since
pax8 is not expressed in the ear past 19 hpf, reduction in the
vesicle and sensory epithelia presumably arise from earlier
deficits in the placode or preplacode resulting from reduced
levels of pax8.
Interactions between pax8 and Fgf genes
Fgf signaling appears to be the principal inducer of otic
development in all vertebrates (Noramly and Grainger, 2002;
Riley and Phillips, 2003). In zebrafish, fgf3 and fgf8 are
expressed in periotic tissues during gastrulation and are
essential for otic induction (Leger and Brand, 2002; Maroon
et al., 2002; Phillips et al., 2001). Furthermore, in the
experimental context of the whole embryo, misexpression of
fgf3 or fgf8 can lead to the formation of ectopic otic placodes
(Phillips et al., 2004). Induction of pax8 expression is the
earliest response to Fgf signaling and does not occur in the
absence of Fgf signaling. We hypothesized that pax8 helps
mediate otic induction or early differentiation in response to
Fgf signaling. In support of this hypothesis, the phenotype
Fig. 2. Assessment of Pax8 function in otic induction.
(A,D) Head region of live wild-type (A) and pax8-MO
injected (D) embryos at 30 hpf. The pax8-MO-injected
embryo has a narrow midbrain-hindbrain border (asterisk),
and small otic vesicles (ov). (B,E) Otic vesicles at 30 hpf in
live wild-type (B) and pax8-MO-injected (E) embryos.
(C,F) Otic vesicles at 30 hpf in embryos injected with v1-
MO to knockdown variant 1 isoforms of pax8 (C) or v2/3-
MO to knockdown variant 2 and 3 isoforms of pax8 (F).
(G,J) pax8 expression at 10 hpf in wild-type (G) and pax8-
MO-injected (J) embryos. (H,K) Expression of pax2a (blue)
and krox20 (red) at 12 hpf in wild-type (H) and pax8-MO-
injected (K) embryos. (I,L) dlx3b expression at 12 hpf in
wild-type (I) and pax8-MO-injected (L) embryos. Images
show lateral views with anterior to the left and dorsal to the
top (A-F); or dorsal views with anterior to the left (G-L).
mhb, midbrain-hindbrain border; op, otic placode; ov, otic
vesicle. Scale bar in L: 200 µm for H,K; 170 µm for G,I,J,L;
150 µm for A,D; 40 µm for B,C,E,F.
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observed in pax8 morphants (Figs 2 and 3) resembles that
observed in embryos disrupted for either fgf3 or fgf8 (Fig.
4E,M). We tested this relationship further by examining the
effects of disrupting pax8 and either fgf3 or fgf8. Because fgf3
and fgf8 are partially redundant, blocking either function alone
causes only moderate reduction in the expression domains of
preotic markers pax8, pax2a, and dlx3b (Fig. 4F-H,N-P), with
corresponding reduction in the size of the otic vesicle (Fig.
4E,M). These tissues are further reduced in embryos depleted
for both pax8 and fgf3 (Fig. 4I-L). Depleting pax8 in ace (fgf8)
mutants causes even more severe deficiencies in otic
development: at early stages, expression domains of pax8 and
pax2a are strongly reduced, upregulation of dlx3b does not
occur, and at later stages the otic vesicle is rudimentary and
produces no hair cells or otoliths (Fig. 4Q-T). It is unclear
whether the stronger interaction of pax8 with fgf8 compared to
fgf3 reflects functional differences between these ligands or
differing degrees of functional disruption. A recent report
suggests that fgf8 plays a more dominant role than fgf3 in early
hindbrain patterning (Wiellette and Sive, 2004), and may thus
also have a more pronounced role in otic induction. In either
case, the above data are consistent with the hypothesis that
pax8 helps mediate the effects of both Fgfs. The fact that otic
development is not totally ablated is consistent with the notion
that pax8 is not the only gene involved in the early response to
Fgf signaling.
Interactions between pax8
and Pax2 genes
Two other Pax genes are
coexpressed with pax8 in preotic
cells, albeit at slightly later stages:
pax2a is expressed in the otic
anlagen by 11 hpf (3 somites) and
pax2b is expressed by 13.5 hpf (9
somites) (Pfeffer et al., 1998). As
closely allied members of the
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Fig. 3. Assessment of Pax8 function in otic vesicle
patterning. (A,E) Otic vesicles at 32 hpf stained with anti-
Pax2 (red) and anti-acetylated tubulin (green) antibodies to
label hair cells (Riley et al., 1999) in wild-type (A) and
pax8-MO-injected (E) embryos. Hair cell patches are
indicated (white arrows). Injected embryos produce fewer
hair cells than normal. In the experiment shown here, an
average of 5.2±1.1 hair cells were seen in pax8 morphants
(n=59 ears), compared to 9.2±1.4 hair cells in wild type
embryos (n=10 ears); 5-10% of pax8 morphants produce
only one macula per ear (not shown). (B,F) pax5
expression at 24 hpf in wild-type (B) and pax8-MO-
injected (F) embryos. (C,G) dlx3b expression at 33 hpf in wild-type (C) and pax8-MO-injected (G) embryos. (D,H) msxC expression marks
developing cristae in the otic vesicle at 78 hpf in wild-type (D) and pax8-MO-injected (H) embryos. The lateral crista is present in the injected
embryo but shows strongly reduced expression of msxC. Defects in development of cristae and semicircular canals are highly variable in pax8
morphants. Images show lateral views with anterior to the left and dorsal to the top. ac, anterior crista; lc, lateral crista; pc, posterior crista.
Scale bar in H: 90 µm for D,H, 40 µm for C,G, and 30 µm for A,B,E,F.
Fig. 4. Interaction of pax8 with fgf3
and fgf8. Wild-type embryos (A-D),
wild-type embryos injected with fgf3-
MO (E-H), wild-type embryos co-
injected with fgf3-MO and pax8-MO
(I-L), ace (fgf8) mutants (M-P), and
ace mutants injected with pax8-MO
(Q-T). Images show lateral views of
the otic vesicle at 30 hpf (A,E,I,M,Q),
and dorsal views of pax8 expression at
10 hpf (B,F,J,N,R), pax2a expression
at 12 hpf (C,G,K,O,S) and dlx3b
expression at 12 hpf (D,H,L,P,T). op,
otic placode. Arrowheads mark the
otic region where dlx3b expression
normally shows marked upregulation.
Anterior is to the left in all specimens.
Op, optic placode. Scale bar in T: 30
µm for A,E,I,M; 200 µm for B-D,F-
H,J-L,N-P,R-T.
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pax2/5/8 family, these three genes could provide multiple
levels of redundancy during otic development. Notably,
embryos deficient in both pax2a and pax2b produce relative
normal otic vesicles, with defects being limited to reduced hair
cell production (Whitfield et al., 2002). This surprisingly mild
phenotype possibly reflects compensation by pax8. Similarly,
later expression of pax2a and pax2b could ameliorate the
effects of disrupting pax8 function. To address these
possibilities, we injected pax8-MO and pax2b-MO into noi
(pax2a) mutants (Fig. 5A′-D′). Early placode development in
pax2a-pax2b-pax8-deficient embryos is similar to that in pax8
morphants. However, by 18 hpf, the otic domain of pax2a is
severely reduced in pax2a-pax2b-pax8-deficient embryos (Fig.
5B′). By 24 hpf, the otic domain of pax2a is lost entirely in
about half of pax2a-pax2b-pax8-deficient embryos (47%,
n=36; Fig. 5C′), and there are no morphological signs of otic
development (Fig. 5D′). Staining with acridine orange
indicates that there is no noticeable increase in cell death in the
periotic region (not shown), suggesting that otic cells
dedifferentiate in the absence of pax2/8 function. In agreement,
about half of pax2a-pax2b-pax8-deficient embryos show
diffuse expression of dlx3b in the otic region or no otic
expression at all (11/30 and 3/30, respectively, Fig. 5E′,F′).
In addition, a scattering of dlx3b-expressing cells appears
Fig. 5. Relative functions of pax8,
pax2a and pax2b. (A-C) pax2a
expression in wild-type embryos at
14 hpf (A), 18 hpf (B) and 24 hpf
(C). (D) Head region of an
uninjected noi (pax2a) mutant at 30
hpf. The otic vesicle has essentially
normal morphology. A′-D′, noi
(pax2a) mutants co-injected with
pax8-MO and pax2b-MO showing
pax2a expression at 14 hpf (A′), 18
hpf (B′) and 24 hpf (C′), and a live
specimen with no otic vesicles at 30
hpf (D′). krox20 expression in the
hindbrain is shown in red (B,B′).
(E,E′,F,F′) dlx3b expression at 24
hpf in a wild-type embryo (E), a
wild-type embryo injected with
pax8-MO (F), and noi (pax2a)
mutants co-injected with pax8-MO
and pax2b-MO (E′,F′). The
specimen in E′ lacks morphological
otic vesicles but does show a
scattering of dlx3b-expressing cells
in the otic region (asterisk). The
specimen in F′ lacks morphological
signs of otic development and also
shows no dlx3b expression in the
otic region (asterisk). G,G′,H,H′,
fgf3 expression in wild-type embryos
at 14 hpf (G) and 19 hpf (H) and in
pax2ba-pax2b-pax8-deficient
embryos at 14 hpf (G′) and 19 hpf
(H′). Expression in the hindbrain
(r4) is normal in all specimens,
whereas expression in the otic
vesicle (ov) is strongly reduced at 19
hpf in pax2a-pax2b-pax8-deficient
embryos (compare H,H′).
(I,I′) sox9a expression at 13.5 hpf in
wild-type (I) and pax2a-pax2b-pax8-
deficient (I′) embryos.
(J-L,J′-L′) claudinA expression in
wild-type embryos at 13.5 hpf (J)
and 24 hpf (K,L), and in pax2a-
pax2b-pax8-deficient embryos at
13.5 hpf (J′) and 24 hpf (K′,L′). M-P, wild-type embryos co-injected with pax8-MO and pax2b-MO showing expression of pax2a at 14 hpf (M)
and 18 hpf (N), the head region of a live specimen with a small otic vesicle at 30 hpf (O), and an enlargement of the otic vesicle of the same
specimen (P). Images show dorsal views with anterior to the left (A,A′G-J,G′-J′,M), dorsal views with anterior to the top (B,B′,C,C′,K,K′,N), or
lateral views with anterior to the left (D-F,D′-F′,L,L′,O,P). a, pharyngeal arches; asterisk, region where otic vesicle normally forms; mhb,
midbrain-hindbrain border; op, otic placode; ov, otic vesicle; r4, rhombomere 4 of the hindbrain. Scale bar in P: 170 µm for
A,A′,G,G′,I,J,I′,J′,M; 75 µm for B-F,B′-F′,H,H′,K,L,K′,L′,N,O; 19 µm for P.
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between the otic territory and pharyngeal arches, a region
normally devoid of dlx3b expression. It is possible that these
ectopic dlx3b-expressing cells are the dispersed remnants of
the otic vesicle. Expression of other otic markers shows similar
results. For example, sox9a expression is initially induced but
is barely detectable in pax2a-pax2b-pax8-deficient embryos by
13.5 hpf (Fig. 5I,I′). claudinA is expressed in a reduced otic
domain at 13.5 hpf. By 24 hpf, about half of pax2a-pax2b-
pax8-deficient embryos show either no claudinA expression
(9/25, Fig. 5K′) or a diffuse scattering of expressing cells, again
suggesting dispersal of otic remnants (5/25, Fig. 5L′). In
summary, otic induction appears no worse in pax2a-pax2b-
pax8-deficient embryos than in pax8 morphants, but the otic
placode is not maintained properly at later stages. Various
hindbrain markers including krox20, fgf3, fgf8, wnt8, and
wnt8b (Fig. 5B′,G′,H′, and data not shown) are induced and
maintained normally, suggesting that the failure to maintain
otic fate is not due to loss of hindbrain signaling.
A similar phenotype to the pax2a-pax2b-pax8-deficient
phenotype is seen in noi (pax2a)-pax8-deficient embryos (not
shown). Because pax2b is still expressed, we infer that pax2b
alone is not sufficient to maintain otic development.
Nevertheless, the frequency of total ear loss in noi (pax2a)-
pax8-deficient embryos (22%, n=23) is lower than in pax2a-
pax2b-pax8-deficient embryos (47%, n=36), suggesting that
pax2b can contribute to otic maintenance. To test this further,
we injected wild-type embryos with pax2b-MO and pax8-MO.
Otic development is similar to that seen in pax8-deficient
embryos through 18 hpf (Fig. 5M,N, and data not shown).
However, pax2b-pax8-deficient embryos produce a much
smaller otic vesicle than pax8-deficient embryos and usually
lacks otoliths (Fig. 5O,P), suggesting significant loss of otic
tissue after the vesicle begins to form. Thus, both pax2a and
pax2b play a role in otic maintenance, but the requirement for
pax2a appears more critical.
Because of the strong interaction between pax8 and pax2a,
we used the noi (pax2a) mutation to provide a sensitized
background in which to test the relative roles of different pax8
splice variants. pax8 variant 1 MO blocks translation of variant
1 isoforms, which lack the N-terminal Paired domain, whereas
pax8 variant 2/3 MO blocks translation of isoforms predicted
to include the entire Paired domain. Injection of pax8 variant
1 MO into noi (pax2a) mutants usually results in production
of a moderately reduced otic vesicle containing hair cells but
no otoliths (83%, n=84, Fig. 6A,B). In contrast, injection of
pax8 variant 2/3 MO into noi (pax2a) mutants ablates the ear
entirely (21/76) or results in production of a relatively
small otic vesicle (55/76). In the latter case, however,
otoliths are usually produced (Fig. 6C,D). The two
translation blockers also differentially affect brain
development in the region of the midbrain-hindbrain
border (MHB). The MHB does not form in noi (pax2a)
mutants. Mutants injected with pax8 variant 2/3 MO
invariably show a persistent and intense band of cell
death localized to the ventral midline of the MHB
region (Fig. 6C,H). This pattern of cell death is never
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Fig. 6. Distinct functions of pax8 splice isoforms. 
(A-D) Lateral views of the head and otic structures at 30 hpf
in noi (pax2a) mutants injected either with pax8 variant 1
MO (A,B) or noi mutants injected with pax8 variant 2/3 MO
(C,D). Most noi mutants knocked down for variant 1
isoforms produce a moderate-sized otic vesicle containing
hair cells but lacking otoliths (B). In contrast, noi mutants
knocked down for variant 2 and 3 isoforms typically produce
a small otic vesicle containing both hair cells and otoliths
(D) or no otic vesicle at all (data not shown). In addition, all
noi mutants knocked down for variant 2 and 3 isoforms
show persistent cell death (cd) in the midbrain-hindbrain
region. (E-H) Dorsal views of the midbrain-hindbrain border region at 30 hpf in an uninjected wild-type embryo (E), an uninjected noi mutant
(F), a noi mutant injected with pax8 variant 1 MO (G) and a noi mutant injected with pax8 variant 2/3 MO (H). Increased cell death is not
evident in the majority of noi mutants knocked down for variant 1 isoforms (A) and, if present (G), cell death is diffuse and limited to
dorsolateral tissue. In noi mutants knocked down for variant 2 and 3 isoforms, cell death is invariably present, intense, and localized to the
midline of the midbrain-hindbrain border region (H). Anterior is to the left (A-D) or to the top (E-F). cd, cell death; mhb, midbrain-hindbrain
border; ot, optic tectum. Scale bar in H: 75 µm for A,C; 50 µm for E-H; 19 µm for B,D.
Fig. 7. pax2a interacts with fgf8. Wild-type embryos (A-C),
ace (fgf8) single mutants (D-F) and ace-noi (fgf8-pax2a)
double mutants (G-I). Images show dorsal views of pax2a
expression at 12 hpf (A,D,G) and 14 hpf (B,E,H), and lateral
views of otic vesicles at 30 hpf (C,F,I). The specimen in B is
the same as in Fig. 5A, and the specimen in C is the same as
in Fig. 2B. Anterior is to the left in all specimens. mhb,
midbrain-hindbrain border; op, otic placode. Scale bar in I:
170 µm for A,B,D,E,G,H; 35 µm for C,F,I.
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observed in uninjected noi (pax2a) mutants nor in
mutants injected with pax8 variant 1 MO (Fig. 6A,F).
Instead, 20-30% of noi (pax2a) mutants injected with
pax8 variant 1 MO show a moderate increase in cell
death in the dorsolateral MHB region (Fig. 6G). The
significance of these differences is unclear at present,
but the data strongly suggest that Pax8 isoforms
containing a complete vs. partial Paired domain have
at least some distinct developmental functions.
Interactions between pax2a and Fgf genes
A role for Pax2 genes in placode maintenance has not
been previously reported, so this function was further
investigated by analyzing the interaction between fgf
genes and pax2a. In ace-noi (fgf8-pax2a) double
mutants, expression of preotic markers is initially
comparable to that seen in ace single mutants.
However, the otic domain of pax2a shrinks
dramatically in ace-noi double mutants such that, by
14 hpf, it is much smaller than in either ace or noi
single mutants (Fig. 7D,E,G,H). ace-noi double
mutants produce only very small otic vesicles
containing few hair cells and no otoliths (Fig. 7I; and
data not shown). In severely affected specimens, otic
vesicles are so small that they can only be detected at
high magnification using DIC optics. Similar results
are obtained when fgf3 is knocked down in noi
(pax2a) mutants (not shown). Presumably, Fgf
depletion impairs early preotic development such that
pax2a function becomes critical for this process.
When pax2a is disrupted in addition to fgf3 or fgf8,
the majority of placodal cells are unable to maintain
otic fate.
Pax8 interaction with other transcription
factors, Foxi1 and Dlx3b
foxi1 is one of the earliest regulators of preotic development
identified (Nissen et al., 2003; Solomon et al., 2003). Loss of
foxi1 causes a severe phenotype characterized by production of
very small otic vesicles or, in severe cases, complete loss of
otic tissue. Expression of pax8 in the otic domain is not
detectable in foxi1 mutants, presumably contributing to the
mutant phenotype. Conversely, misexpression of foxi1 is
sufficient to induce ectopic expression of pax8, suggesting that
Foxi1 serves as an upstream activator of pax8 expression. To
test this predicted epistatic relationship, we co-injected foxi1-
MO and pax8-MO into wild-type embryos. Knockdown of
foxi1 and pax8 causes defects in otic development that are
indistinguishable from the effects of injecting foxi1-MO alone
(Fig. 8A-F), supporting the notion that foxi1 and pax8 function
in a simple linear pathway.
dlx3b is another early regulator of preotic development, and
mutants homozygous for a deletion that removes dlx3b (as well
as dlx4b and sox9a) show severe deficiency of otic tissue.
However, they show nearly normal expression of pax8
(Solomon and Fritz, 2002). Furthermore, early expression of
dlx3b along the edges of the neural plate is independent of Fgf
signaling and pax8 function (Fig. 4). These and other data
strongly suggest that pax8 and dlx3b are at least initially in
independent pathways. To investigate the epistatic relationship
between these genes, embryos were co-injected with dlx3b-
MO and pax8–MO. In dlx3b-pax8 double morphant embryos,
preotic domains of dlx3b and pax2a are reduced relative to
those seen in embryos depleted for dlx3b or pax8 alone (Fig.
8H,I,K,L). Otic vesicles are dramatically reduced in size and
typically produce no hair cells or otoliths (Fig. 8G,J; and
data not shown), indicating severe deficiencies in otic
differentiation. These findings show that pax8 and dlx3b do not
operate in a simple linear pathway.
Discussion
Exonic structure of pax8
We have completed the pax8 cDNA sequence and identified
three main variants of transcripts with several subvariants
present. While most features of the exon-intron structure are
conserved with mammalian Pax8, the zebrafish sequence
shows several unique features. Most significantly, we identified
three main categories of splice variants that vary in their N-
terminal sequences, leading to the use of two alternative start
codons. The predicted ORF for variant 1 begins ten amino
acids within the canonical Paired domain and would
presumably disrupt the DNA-binding ability of the N-terminal
portion of this domain (Xu et al., 1995). Variants 2 and 3
encode proteins that contain the entire canonical Paired
domain. The Paired domain comprises N-terminal and C-
Fig. 8. pax8 acts downstream of foxi1 and in parallel with dlx3b. Wild-type
embryos injected with foxi1-MO (A-C), foxi1-MO plus pax8-MO (D-F), dlx3b-
MO (G-I), or dlx3b-MO plus pax8-MO (J-L). Images show lateral views of the
otic vesicle at 30 hpf (A,D,G,J), or dorsal views of dlx3b expression at 12 hpf
(B,E,H,K) and pax2a expression at 12 hpf (C,F,I,L). Anterior is to the left in all
specimens. mhb, midbrain-hindbrain border; op, otic placode. Arrowheads mark
the otic region of dlx3b expression. Scale bar in L: 50 µm for A,D,G,J; 200 µm
for B,C,E,F,H,I,K,L.
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terminal subdomains, which mediate binding to distinct parts
of a conserved DNA consensus sequence. Although no
isoforms using alternate start codons have been identified in
the mouse or human, one mammalian isoform, Pax8(S),
contains an additional serine residue in the N-terminal
subdomain. This insertion functionally inactivates the N-
terminal subdomain, causing Pax8(S) to bind a different DNA
consensus sequence through its C-terminal subdomain,
perhaps analogous to the zebrafish variant 1 vs. variant 2-3
isoforms. Pax8(S) accounts for roughly one-third of Pax8
produced in all tissues, extending the range of target genes
potentially regulated by the Pax8 locus (Kozmik et al., 1997).
It is possible that the zebrafish isoform with an incomplete N-
terminal subdomain has altered binding properties similar to
mammalian Pax8(S). Interestingly, Fugu pax8 also encodes a
methionine at position 10 of the Paired domain (Pfeffer et al.,
1998), and thus may encode a set of Pax8 proteins similar to
zebrafish. Although the exact functional differences between
these isoforms remain to be elucidated, our data suggest that
variant 1 and variant 2/3 isoforms appear to have both
overlapping and unique functions as revealed by knockdown
in the noi (pax2) mutant background.
At least six splice variants found in the mouse and human
show changes in C-terminal sequences (Kozmik et al., 1993),
and even more C-terminal variants are found in zebrafish.
Other Pax8 functional domains, including the transactivation
domain and the inhibitory domain, are disrupted in these
isoforms. The functional significance of C-terminal variation
is presently unknown; however, altering the structure of the
functional domains may create proteins with altered DNA
sequence specificity or varying transactivation potentials, as
has been previously reported for other members of the
zebrafish and mammalian Pax gene families (Barber et al.,
1999; Barr et al., 1999; Epstein et al., 1994; Kozmik et al.,
1997; Kozmik et al., 1993; Nornes et al., 1996; Puschel et al.,
1992; Seo et al., 1998; Tavassoli et al., 1997; Vogan et al.,
1996; Zwollo et al., 1997). It should be noted that these
alternatively spliced isoforms appear to be rare in zebrafish.
Redundancy among Pax2 and pax8 genes
Knockdown of pax8 causes significant reduction in the amount
of otic tissue produced during induction, and the deficit persists
through subsequent stages of otic development. The small
vesicle that is eventually produced expresses regional markers
normally but shows deficiencies in sensory epithelia. In severe
cases, various maculae or cristae are missing or fused, possibly
as a nonspecific consequence of the presence of too little otic
tissue. The closely related genes pax2a and pax2b are
expressed at slightly later stages of preotic development and
appear to partially overlap in function with pax8. Disruption of
both pax2a and pax2b function causes only subtle defects in
otic development, suggesting that pax8 can substantially
compensate for their loss. When the function of all three Pax
genes is disrupted, otic tissue shows progressive diminution
during placodal development and is lost entirely by 24 hpf.
Staining with acridine orange does not reveal an obvious
increase in otic cell death, suggesting that otic these cells
eventually dedifferentiate in the absence of otic maintenance
mediated by pax2a, pax2b, and pax8. This notion is further
supported by the observation that the otic domain of dlx3b
expression appears to be progressively lost beginning around
24 hpf. These data strongly support the hypothesis that pax8
and pax2 functions are partially redundant. A similar
relationship among murine Pax2/5/8 family members seems
likely as well. Pax8 and Pax2 are expressed in the developing
murine ear at the same relative stages as in zebrafish (Pfeffer
et al., 1998). No ear defects have been reported in Pax8
knockout mice (Bouchard et al., 2002; Mansouri et al., 1998),
and defects in Pax2 knockout mice are limited to disturbances
in medial otic vesicle development (Bouchard et al., 2000;
Burton et al., 2004; Favor et al., 1996; Torres et al., 1996). Otic
development has not yet been described in Pax8-Pax2 double
knockout mice, but it seems likely that much more severe otic
defects will result in such embryos. Indeed, such has been
observed with respect to kidney development (Bouchard et al.,
2002). The developing kidney undergoes apoptotic cell death
at an early stage in Pax8-Pax2 double mutants, a phenotype not
observed in either of the single mutants (Bouchard et al., 2002).
pax8 as part of a genetic network.
Induction of pax8 expression requires at least two distinct
pathways, one mediated by foxi1 and the other by Fgf signaling
(Leger and Brand, 2002; Maroon et al., 2002; Nissen et al.,
2003; Phillips et al., 2001; Solomon et al., 2003; Solomon et
al., 2004). These inductive pathways are partially independent,
but some aspects of foxi1 expression appear to be regulated by
Fgf signaling. foxi1 is initially expressed in ventral ectoderm
but then shows upregulation in periotic ectoderm roughly 30-
60 minutes before induction of pax8. The spatial pattern of
foxi1 expression is unaltered in embryos depleted for Fgf3 and
Fgf8 (Solomon et al., 2004), but misexpression of Fgf3 or Fgf8
is sufficient to induce foxi1 expression in ectopic locations
(Phillips et al., 2004). It is possible that foxi1 is sensitive to
residual Fgf signaling in Fgf morphants or, alternatively, Fgf3
and Fgf8 may act in concert with other factors to regulate foxi1.
In any case, expression of pax8 occurs in the region where
foxi1 and Fgf signaling overlap, and serves as an important
nexus linking these pathways.
Our data also indicate that pax8 positively regulates its own
expression since the level of pax8 expression is reduced in pax8
morphants. We speculate that pax8 helps mediate otic
induction and that this feedback loop magnifies the efficacy of
Fgf signaling, extending the range of Fgf action to cells farther
from the source. Thus, loss of pax8 would be expected to limit
otic induction to cells in close proximity to the signaling
source, a prediction borne out by our studies. Subsequent
expression of pax2a and pax2b, which require Fgf signaling
but not pax8, presumably stabilizes otic fate within the
diminished population of preotic cells. Such a model could
explain why eliminating Pax8 in the mouse has such mild
consequences; in the mouse, Fgf3 is expressed directly within
preotic cells, making the need for signal amplification less
critical during initial stages of otic induction. Later expression
of Pax2 might then be sufficient to stabilize otic development
initiated by prior Fgf signaling.
A number of other transcription factors have been implicated
in early otic development, the best characterized of which are
dlx3b and dlx4b. dlx3b/4b are initially expressed in ventral
ectoderm but become restricted by 9 hpf to a contiguous line
of cells surrounding the neural plate (Akimenko et al., 1994).
By 11 hpf, dlx3b/4b show strong upregulation in preotic cells.
The early phases of dlx3b/4b expression are independent of Fgf
Development 132 (2) Research article
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signaling, but later upregulation in the otic anlagen fails to
occur in embryos depleted for Fgf3 and Fgf8 (Liu et al., 2003;
Solomon, 2004); (this report). As such, dlx3b and dlx4b could
serve as another mediator of Fgf signaling (Solomon, 2004).
Knockdown of either dlx gene causes mild to moderate
deficiencies in otic development, with much more severe
deficiencies seen in embryos knocked down for both (Liu et
al., 2003; Solomon and Fritz, 2002). Embryos homozygous for
a deletion that removes dlx3b, dlx4b and sox9a (a third preotic
marker under control of Fgf signaling) fail to produce an ear,
although roughly one-third of mutant embryos produce a few
disorganized otic cells that belatedly express pax2a. This
severe disruption occurs despite the fact that pax8 is initially
expressed normally (Solomon and Fritz, 2002). Thus, pax8 is
clearly not sufficient to sustain early otic development. Other
transcription factors also play crucial roles during otic
induction.
In this paper, we have shown that knockdown of both pax2a
and pax8 causes much more severe loss of ear tissue than
knocking down either alone. We have previously shown that
foxi1, which is required for pax8 expression in the otic domain,
and dlx3b act in parallel pathways in early otic placode
formation and show a strong synergistic genetic interaction
(Solomon, 2004). The pax8-dlx3b morphant analysis confirms
these previous results and furthermore suggests that a
significant aspect but not all of foxi1 function is mediated by
pax8. Thus, there appear to be multiple regulatory genes that
respond to Fgf signaling and help mediate its effects. Each is
likely to control both redundant and specific functions; hence
there is neither a single ‘master regulator’, analogous to the
role played by pax6/eyeless during eye development, nor an
‘all-or-none’ combinatorial code required for otic induction.
This model partly accounts for the remarkable resilience and
regulative capacity of the developing inner ear (Baker and
Bronner-Fraser, 2001; Noramly and Grainger, 2002; Riley and
Phillips, 2003; Torres and Giraldez, 1998). A similar series of
experiments involving pax2-pax8, dlx3b, foxi1, fgf3-fgf8 and
sox9 genes has been performed by Hans and colleagues (Hans
et al., 2004). They propose a model that fully agrees with the
findings and conclusions presented here (Hans et al., 2004), as
well as the model proposed by Solomon et al. (Solomon et al.,
2004).
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